Sickle Cells Disease

The CRISPR/Cas9 gene-editing system already is producing results that may fundamentally transform the treatment of certain diseases, according to one of the recipients of the 2020 Nobel Prize in Chemistry.

Among Black adults, those with sickle cell trait or disease had a higher likelihood of developing AKI compared with those who had a normal hemoglobin phenotype, according to a study.